Clinical Trials Browser

Phase 2 × INDUSTRY × AZD4547 × Clear all

NCT05775874 2023-03-20

A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT01457846 2017-03-07

SHINE

Phase 2 Terminated

960 enrolled 13 charts

Gastrointestinal

Stomach Neoplasms